hepatomiR cACLD Study

RecruitingOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Chronic Liver Disease and CirrhosisChronic Liver DiseasePortal Hypertension
Interventions
DIAGNOSTIC_TEST

hepatomiR

hepatomiR is a CE-certified test intended for gauging liver-related outcomes. It quantifies the levels of hsa-miR-122-5p, hsa-miR-192-5p, and hsa-miR-151a-5p in human plasma samples. A proprietary algorithm is then used to compute a liver function score (hepatomiR p-score).

Trial Locations (1)

3100

RECRUITING

University Hospital St. Pölten, Sankt Pölten

All Listed Sponsors
collaborator

University Hospital St. Polten

OTHER

lead

Karl Landsteiner University of Health Sciences

OTHER